Skip to content

The Relation Between BSS Solution Temperature and Endothelial Cells and Post Phaco Discomfort

The Relation Between BSS Solution Temperature and Endothelial Cells and Post Phaco Discomfort

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06904560
Enrollment
40
Registered
2025-04-01
Start date
2025-04-01
Completion date
2025-07-01
Last updated
2025-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal Diseases

Keywords

cornea, cataract

Brief summary

patients underwent phacoemulsification , balanced saline solution used during the operation will be at room temperature in one group and cool 2.7 c in the other group. the patients will be followed for 3 months after phacoemulsification regarding corneal endothelial cells and anterior segment inflammatory signs

Detailed description

patients underwent phacoemulsification , balanced saline solution used during the operation will be at room temperature in one group and cool 2.7 c in the other group. the patients will be followed for 3 months after phacoemulsification regarding corneal endothelial cells and anterior segment inflammatory signs

Interventions

OTHERphacoemulsification

one group with BSS at room temperature and the other group with cold BSS

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* patients with cataract * more than 40 years * no glaucoma * no retinal abnormalities * no retinal abnormalities

Exclusion criteria

patients with corneal diseases patients less than 40 patients with previous eye surgery

Design outcomes

Primary

MeasureTime frame
endothelial cell count3 months

Secondary

MeasureTime frameDescription
incidence of anterior segment inflammation3 monthsincidence of anterior segment inflammation including conjunctival hypremia or corneal edema

Contacts

Primary ContactHany Mahmoud
drhanymahmoud@gmail.com01024368111

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026